I’ll be at AACR — Join me April 21 in San Diego

AN INVITATION FROM STAT'S DAMIAN GARDE

Dear readers,

New medicines have fostered hope for patients with cancers once considered “undruggable,” while futuristic cell therapies are moving into the mainstream, and AI promises to upend the practice of oncology.

It’s all coming to a head at the American Association for Cancer Research’s annual meeting in San Diego later this month. STAT will be on the ground covering the meeting, and, for the first time ever, we’re hosting an evening event with leading experts in the field to break down the latest data and what they mean for the future of cancer care.

Join us Tuesday, April 21, to hear from Susan Galbraith, head of oncology research at AstraZeneca, and Gregory Verdine, a pathbreaking scientist and entrepreneur, about the next wave of practice-changing medicines in the pipeline.

RSVP HERE

We’ll also sit down with three of the world’s top cancer doctors — Robert Winn of VCU, departing AACR president Lillian Siu of the University of Toronto, and incoming AACR president Keith Flaherty, a physician at Massachusetts General Hospital who co-founded Loxo Oncology and Scorpion Therapeutics — to explain the headline-making results presented at the meeting and the state of oncology in 2026.

We’ll have drinks, light bites, and plenty of opportunities to network. If you’re heading to San Diego for AACR, you won’t want to miss it. Hope to see you there.

RSVP here to secure your spot